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ChinaWe explored the timescale, spatial spread, and risk group population structure of HIV-1 subtype B', the cause
of explosive blood-borne HIV-1 epidemics among injecting drug users (IDUs) and former plasma donors
(FPDs) in Asia. Sequences from FPDs in China formed a distinct monophyletic cluster within subtype B'.
Further analysis revealed that subtype B' was founded by a single lineage of pandemic subtype B around
1985. Subsequently, the FPD cluster appears to have derived from a single subtype B' lineage around 1991,
corroborating the hypothesis that FPD outbreaks stemmed from the preceding epidemic among IDUs in
Southeast Asia, most likely from the Golden-Triangle region.ology and Epidemiology, AIDS
, 1-23-1 Toyama, Shinjuku-ku,
ork.
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HIV-1 subtype B' (Thailand variant of subtype B; also referred to as
Thai-B or BB) (Kalish et al., 1995; Ou et al., 1993; Weniger et al., 1994)
is a unique regional variant of subtype B that has caused explosive
epidemics in Asia via the routes of blood-borne transmission, namely
networks of injecting drug users (IDUs) (Ou et al., 1993) and
unhygienic plasma collection (Mastro and Yip, 2006). The strain
was originally identiﬁed among IDUs in Bangkok, Thailand (Ou et al.,
1993) and dominated the early phase of the HIV epidemic in Bangkok
that began in December 1987 (Kalish et al., 1995; Ou et al., 1993).
However, as the epidemic matured, the proportion of CRF01_AE
infections in Bangkok increased relative to B', to the extent that in
1995–1998 about 80% of new IDU infections in the city were caused by
CRF01_AE (Subbarao et al., 2000). In contrast, subtype B' is almost theonly strain found among IDUs in Yangon, the capital city of Myanmar,
and even predominates among heterosexuals in Myanmar, account-
ing for more than 30% of infections (Kusagawa et al., 1998; Motomura
et al., 2003).
It has also reported that subtype B' is a single founder strain
responsible for a series of HIV-1 outbreaks among former plasma
donors (FPDs) in Central China (Deng et al., 2008; Zhang et al., 2004).
An estimated 250,000 people, mostly rural peasants, were infected
through unhygienic plasma collection from the early 1990s (from
∼1992) until 1996, when the practice was banned (Mastro and Yip,
2006). The most heavily affected provinces were Henan, Anhui, Hubei
and Shandong in Central China (Mastro and Yip, 2006).
In addition to being an epidemiologically important strain by itself,
subtype B' is also a constituent of up to six different circulating
recombinant forms (CRFs) in Asia, most notably CRF07_BC (Su et al.,
2000) and CRF08_BC (Piyasirisilp et al., 2000) in China, which are
descendants of subtypes B' and C. Four CRFs comprised of CRF01_AE and
subtype B' have been reported to date: CRF15_01B (Tovanabutra et al.,
2003) and CRF34_01B (Tovanabutra et al., 2007) from Thailand:
CRF33_01B (Tee et al., 2006) and CRF48_01B (Li et al., in press) from
Malaysia (http://www.hiv.lanl.gov/content/sequence/HIV/CRFs/).
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forms (URFs) that harbor subtypeB' geneticmaterial havebeen found in
Asian countries, including Thailand (Kijak et al., 2007), Myanmar
(Takebe et al., 2003), Malaysia (Tee et al., 2006; Wang et al., 2007) and
the Yunnan province of China (Qiu et al., 2005; Yang et al., 2002).
Recently developed phylogenetic and molecular clock methods
can be used to reconstruct the epidemic history of HIV and to estimate
the time of the common ancestors of speciﬁc strains (Drummond and
Rambaut, 2007). Such evolutionary analyses help to enhance our
understanding of the genesis and development of global and regional
HIV-1 epidemics.
A previous study by Deng et al. estimated that the common ancestor
of subtype B' existed around 1985 (Deng et al., 2008). Historical
accounts suggest that subtype B' outbreaks began among IDUs in
Thailand and neighboring regions in the late 1980s (Weniger et al.,
1994), prior to the outbreaks among FPDs in China in early-mid 1990s
(Mastro and Yip, 2006). In this study, we re-examined the space–time
process of the overland dissemination of HIV-1 subtype B' – a strain that
is uniquely associated with blood-borne transmission routes in Asia.Results
To carry out the analysis, we selected a 1.6-kb gag-pol region
(HXB2: 1789–3421) of subtype B' because this region maximizes the
length of the nucleotide sequences, whilst simultaneously resulting
in a sufﬁcient number of sequences from various countries and risk
populations from the database. A total of 92 of all available subtype B'
sequences, sampled between 1994 and 2006, were obtained from the
Los Alamos HIV Sequence Database (www.hiv.lanl.gov). Sampling
locations were Thailand (n=6), Myanmar (n=1), Yunnan (south-
western China) (n=10), Henan (Central China) (n=4), Hubei
(Central China) (n=45), and Liaoning (Northeastern China) (n=26).
Using the molecular clock approach implemented in BEAST v1.4
(Drummond and Rambaut, 2007), we estimated the timescale of
subtype B' evolution from the known sequence sampling dates, which
ranged from 1983 to 2005. Estimations were obtained using a
Bayesian Markov chain Monte Carlo (MCMC) method under various
nucleotide substitution and evolutionary models (Table 1). The
estimated evolutionary rates were 3.1 (2.5–3.8)×10−3 and 3.4 (2.7–
4.0)×10−3 substitutions/site/year for GTR+Γ4 and HKY+Γ4models
with a constant size coalescent model (see Materials and Methods)
and 3.0 (2.5-3.5)×10−3 and 3.1 (2.6–3.6)×10−3 substitutions/site/
year for GTR+Γ4 and HKY+Γ4 models with a skyline coalescent
model (Table 1).
As shown in amaximum clade credibility (MCC) tree in Fig. 1, HIV-
1 subtype B' circulating among FPDs (designated B'FPD) in Henan,
Hubei and Liaoning formed a monophyletic cluster within subtype B'.
In other words, subtype B' showed paraphyletic relationship with
respect to B'FPD, indicating that B'FPD is a descendant lineage of
subtype B'.Table 1
Estimated substitution rates and dates origin for HIV-1 subtype B/B' lineages.
Genetic region Modela Rate of
evolutionb
Coefﬁcie
of variat
gag-pol subtype B' (HXB2: 1789-3421) GTR+Γ4 Constant 3.1 (2.5, 3.8) 0.5 (0.3,
HKY+Γ4 Constant 3.4 (2.7, 4.0) 0.5 (0.3,
GTR+Γ4 Skyline 3.0 (2.5, 3.5) 0.3 (0.3,
HKY+Γ4 Skyline 3.1 (2.6, 3.6) 0.3 (0.3,
(Mean)
a Based on BEAST analysis under a relaxed molecular clock with a GTR+Γ4 or HKY+Γ4
b Estimates of the mean evolutionary rate (μ: × 10-3 nucleotide substitutions/site/year)
c Mean time of the most common ancestor (tMRCA: year) for the subtype B/B' dataset [95%
B' (IDU)=subtype B' strains that is responsible for HIV-1 outbreaks among injecting drug us
outbreaks among former plasma donors (FPDs) in Central China.The Bayesian relaxed molecular clock analysis estimated the date of
the common ancestor of subtype B' to be 1984.5 (95% credible region,
CR: 1980.9–1987.7) (Fig. 1). This is in good agreementwith Deng et al.'s
previousestimate (Denget al., 2008). In contrast, the likely yearof origin
of the B'FPD clade was estimated at 1991.2 (95% CR: 1989.1–1993.5)
(Fig. 1, Table 1). We date the tMRCA of pandemic subtype B (B'PAN) to
1966.0 (95% CR: 1957.9–1973.1), consistent with the results of Gilbert
et al. (2007). The evolutionary and statistical assumptions have no
signiﬁcant effect on the estimated dates (Table 1).Discussion
In this study,we used newly developed analysis tools to investigate
the temporal and spatial dynamics of HIV-1 subtype B' transmission, a
regional variant of HIV-1 subtype B that caused explosive epidemics
among IDUs in southeast Asia and FPDs in Central China.
As shown in Fig. 1, HIV-1 strains circulating among FPDs (B'FPD)
formed a monophyletic cluster within subtype B'. As subtype B' is
paraphyletic with respect to B'FPD, B'FPD is likely a descendant lineage
of subtype B'. The Bayesian molecular clock analysis estimated the
date of the common ancestor of subtype B' to be 1984.5 (95%
CR: 1980.9–1987.7). In contrast, the estimated date of origin of the
B'FPD clade was more recent, at 1991.2 (95% CR: 1989.1–1993.5)
(Fig. 1, Table 1). Taken together, these results indicate that the
epidemic among FPDs in China was triggered in early 1990s by a
single lineage of subtype B' emerging from the IDU risk population.
In the present analysis, we chose a 1.6-kb gag-pol region (HXB2:
1789–3421) in order to maximize the phylogenetic resolution. In
practice, this is the only region for which we can obtain a sufﬁcient
number of nucleotide sequences from various countries and risk
populations (i.e., IDUs and FPDs) whilst concurrently maximizing the
length of the nucleotide sequences available. In addition to this 1.6-kb
gag-pol region, we also investigated 325 sequences representing a
351 nt region of the env gene (HXB2: 7050–7400) as well as 488
sequences representing a 485 nt region of gag p17 (HXB2: 790–1274).
Analyses of these shorter regions suggest a general trend distin-
guishing B'FPD from subtype B' but did not contain signiﬁcant
statistical support for this separation. Deng et al.'s analysis (Deng
et al., 2008) used comparatively short nucleotide sequences (483 nt
of gag and 216 nt of env), which likely explains why we identiﬁed a
distinct B'FPD subcluster in our study using 1.6-kb long sequences.
In the gag-pol phylogeny, the B' sequences that are most closely
related to the B'FPD cluster are the isolates from western Yunnan
province (Dehong district) (Fig. 1). We have previously shown that
subtype B' is found exclusively in the western part (Dehong district)
of Yunnan province (Fig. 2B), near the border with Myanmar, where
the ﬁrst HIV-1 epidemic among IDUs in China began in 1989 (Yang
et al., 2002). It is thus tempting to speculate that a founder strain of
the B'FPD cluster originated from one of the B' lineages present in
western Yunnan and subsequently transferred to the FPD risk group innt
ion
Date of tMRCA yearc
B (Pandemic) B' (IDU) B' (FPD)
0.6) 1965.0 (1953.2, 1974.3) 1984.1 (1980.7, 1987.8) 1991.1 (1988.6, 1993.4)
0.6) 1965.8 (1955.8, 1974.1) 1984.0 (1980.4, 1987.7) 1991.2 (1988.8, 1993.4)
0.4) 1970.7 (1964.5, 1976.3) 1985.0 (1981.7, 1988.5) 1991.5 (1989.5, 1993.5)
0.4) 1970.7 (1965.0, 1975.8) 1984.7 (1981.4, 1988.1) 1991.6 (1989.5, 1993.5)
1968.1 (1959.6, 1975.1) 1984.5 (1981.1, 1988.0) 1991.4 (1989.1, 1993.5)
substitution model and a constant size coalescent or skyline model.
for subtype B/B'.
highest posterior density (HPD) in parentheses]. B (pandemic)=pandemic subtype B;
ers (IDUs) in Southeast Asia; B' (FPD) = subtype B' strains that is responsible for HIV-1
Fig. 1. Evolutionary characteristics of HIV-1 subtype B'. Maximum clade credibility (MCC) tree of 1.6-kb gag-RT sequences obtained by Bayesian MCMC analysis is shown (see texts
for details). HIV-1 subtype C sequences (86ETH2220, 95IN21068 and 92BR025d) were used as outgroups. The tips of the tree correspond to the year of sampling, and the branch
lengths reﬂect the mean of the posterior probability density. The 95% highest probability density (HPD) for each subtype B/B' cluster is indicated as a horizontal bar at the
corresponding node. Inset, distribution of the posterior probability for the tMRCAs for the respective subtype B/B' lineage. The symbols for the geographic origins of the respective
subtype B/B' strains are listed in the left-hand panel. The tMRCAmeans and 95% HPDs for the key nodes were as follows: pandemic subtype B ancestor=1966 (1958-1973); subtype
B' ancestor=1985 (1981-1988); B'FPD ancestor=1991 (1989-1994). The asterisk indicates two subtype B' isolates fromwestern Yunnan (Dehong district). The dagger indicates one
of the earliest subtype B isolate (RF) from a Haitian immigrant living in the United States. (Gilbert et al., 2007).
225Rapid CommunicationCentral China. This process may be related to drug trafﬁcking between
the Golden triangle area and Central China (Fig. 2B).
Fig. 2 summarizes the epidemic history and plausible migration
pathway of subtype B/B' lineages in Asia. As reported by Gilbert et al.,
subtype Bmoved from Africa to Haiti around ∼1966 (1962–1970) and
began to disperse around ∼1969 (1966–1972), to the United States
and elsewhere around the world (Gilbert et al., 2007). In Asia, subtype
B' emerged from a pandemic subtype B lineage around ∼1985, trig-
gering an explosive epidemic among IDUs in Thailand and neigh-
boring countries (including Myanmar, Western Yunnan, Malaysia and
eastern India) (Weniger et al., 1994). Most recently, a speciﬁc variant
of B' (B'FPD) emerged in ∼1991 which triggered outbreaks among
FPDs in Central China (Fig. 2).
Our study suggests that subtype B epidemics in Asia arose by the
sequential introduction of founder strains into new locations and risk
groups (Fig. 2B). There appear to be surprisingly few “successful”
migration events, compared to the number of times that we might
expect the virus to move from one place to another and from one risk
population to another risk population. A similar phenomenon has been
also observed in the global migration of CRF01_AE (Liao et al., 2009).
This remarkable epidemic success of subtype B' and B'FPD appears to
reﬂect ecological/epidemiological factors rather than viral geneticfactors (i.e., differences in transmission ﬁtness), although we cannot
formally rule out the possibility of selection at present. We do not
observe any appreciable differences between HIV-1 subtype B, B' and
B'FPD in their virological properties during growth in cell culture. Social
factors, including pre-existing IDU networks and unhygienic plasma
collection fueled the explosive spread of viruses in the regions, resulting
in such profound founding effects. The analysis we reported here
provides insights for in-depth understanding the origin and genesis of
blood-borne HIV-1 epidemic in this particular region in Asia.
Materials and methods
Divergence time estimation
Investigation of the evolutionary history of the HIV-1 subtype B'
strains was carried out using BEAST v1.4 (Drummond and Rambaut,
2007), in order to estimate the tMRCA of each phylogenetic cluster
(Drummond et al., 2002; Pybus et al., 2003). The timescale of subtype
B/B' evolution was estimated using a relaxed molecular clock model
from the known sampling times of the B/B' sequences (Table 1 and
Fig. 1). Relaxed-clock models have previously been shown to be more
reliable in estimating viral phylogenies and divergence dates than
Fig. 2. Schematic representation of space–time dynamics of expansion of HIV-1 subtype B/B' lineages in Asia and the world. (A) Epidemic history of subtype B/B' lineages. The
expected times of origin of the respective clusters are indicated with the historical landmarks relevant to the study. (B) Plausible pathway and timing of dispersal of subtype B' in
Asia. B'PAN, Pandemic subtype B; B', subtype B' triggering IDU epidemic in Southeast Asia; B'FPD, subtype B' variant distributed among former plasma donors (FPDs) in Central China.
The plausible sites of the emergence of six CRFs known to date in which subtype B' is a constituent are shown in the map. The estimated tMRCAs (asterisked) for HIV-1 subtype B/D
common ancestor (*) (Gilbert et al., 2007) and HIV-1 group M (**) (Korber et al., 2000) are indicated according to the respective references.
226 Rapid Communication“strict clock” and “non-clock” methods (Drummond et al., 2006;
Lemey et al., 2006). Dates were estimated using Bayesian MCMC
inference under a variety of coalescent and substitution models. Both
the general time-reversal (GTR) (Rodriguez et al., 1990) and
Hasegawa–Kishino–Yano (HKY) (Hasegawa et al., 1985) nucleotide
substitution models, plus a gamma-distribution model of among site
rate heterogeneity (with four rate categories) (Yang, 1994), were
investigated. The relaxed clock model used was the uncorrelated
lognormal model (Drummond et al., 2006). Two coalescent models
of population size were applied: the constant size model and theBayesian skyline plot model (Table 1). The analysis was computed for
20 million states sampled every 10000 states. The MCMC output was
tested for convergence and effective sample size using Tracer v1.4
(available from http://beast.bio.ed.ac.uk).
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